Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 25, 2021

SELL
$8.38 - $10.18 $125,700 - $152,700
-15,000 Closed
0 $0
Q1 2019

Apr 26, 2019

SELL
$15.58 - $20.01 $4,674 - $6,003
-300 Reduced 1.96%
15,000 $235,000
Q3 2018

Oct 19, 2018

SELL
$21.06 - $25.65 $63,179 - $76,950
-3,000 Reduced 16.39%
15,300 $330,000
Q2 2018

Jul 17, 2018

BUY
$16.77 - $24.71 $50,310 - $74,130
3,000 Added 19.61%
18,300 $445,000
Q4 2017

Feb 13, 2018

SELL
$11.23 - $19.1 $171,819 - $292,230
-15,300 Reduced 50.0%
15,300 $290,000
Q4 2017

Jan 22, 2018

BUY
$11.23 - $19.1 $171,819 - $292,230
15,300 Added 100.0%
30,600 $580,000
Q3 2017

Nov 08, 2017

SELL
$15.41 - $32.17 $235,773 - $492,201
-15,300 Reduced 50.0%
15,300 $269,000
Q3 2017

Oct 12, 2017

BUY
$15.41 - $32.17 $471,546 - $984,402
30,600
30,600 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.